Fulcrum Therapeutics(FULC) - 2024 Q4 - Earnings Call Transcript

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2024 Earnings Conference Call February 25, 2025 8:00 AM ET Company Participants Alex Sapir - President & CEO Alan Musso - CFO Iain Fraser - SVP, Early Development Conference Call Participants Rick Miller - Cantor Fitzgerald Joseph Schwartz - Leerink Partners Matthew Biegler - Oppenheimer Edward Tenthoff - Piper Sandler Anish Nikhanj - RBC Capital Operator Good morning, and welcome to Fulcrum Therapeutics Fourth Quarter and Full Year 2024 Financial Results and Busi ...